Key result
Hypertension management by non-physician healthcare workers proves generally cost-effective in low- and middle-income countries.
Why the study?
This review was conducted to assess the cost-effectiveness and implementation strategies of hypertension management by non-physician healthcare workers in low- and middle-income countries.
Is hypertension management by non-physician healthcare workers cost-effective in adults in low- and middle-income countries?
Systematic Review (n=14,497)
Is hypertension management by non-physician healthcare workers cost-effective in adults in low- and middle-income countries?
Hypertension management by non-physician healthcare workers is a cost-effective strategy for improving blood pressure control in low- and middle-income countries.
Supports task-shifting hypertension care to non-physicians in LMICs; strengthens cost-effectiveness evidence for scalable BP programs.
Background: This review assessed the cost-effectiveness and implementation strategies of hypertension management by non-physician healthcare workers (NPHCWs) in low- and middle-income countries (LMICs). Methods: A systematic search (inception-May 2024) included adults ≥18 years managed by NPHCWs LMICs, following Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. Economic evaluations were assessed using Drummond's checklist and ROBINS-I. Results: Seven studies (2002-2022) conducted across eight countries enrolled 96-10,000 participants and included randomized, modeling, observational, and quasi-experimental designs. NPHCWs included pharmacists, community and village health workers, and nurses. Patients' mean age ranged 58-71 years, with 57-82% female. Outcomes assessed included cost per mmHg reduction ($INT 2.25 systolic, $INT 2.03 diastolic), per controlled patient ($INT 1.48), annual cost ($INT 0.22-232.31), cost per disability-adjusted life year (DALY) averted ($INT 411.39-4709.96), and per quality-adjusted life year (QALY) gained ($INT 1.04-13.30). Incremental cost-effectiveness ratio (ICERs) varied ($INT 0.41-14,373.97). Strategies included NPHCWs training and community engagement/counseling. Conclusion: Hypertension management by NPHCWs appears cost-effective in LMICs, though more studies are needed for generalizability.
No takes yet. Share an insight, caveat, or question.
Shedul et al. (2026) conducted a systematic review in Hypertension (n=14,497). Hypertension management by non-physician healthcare workers (NPHCWs) vs. Usual care was evaluated on Cost-effectiveness (cost per DALY averted, cost per QALY gained, ICER). Hypertension management by non-physician healthcare workers in low- and middle-income countries was generally cost-effective, with the cost per disability-adjusted life year averted ranging from $INT 411.39 to 4709.96.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: